PI Industries Limited CC-May26.pdf · 2026-05-20
Sure. Thanks for the opportunity. My questions are centered around the electronic chemical s market. So, typically we have mentioned in the previous call about, commercializing about four to five molecules. So, if you could share some details in terms of the molecules, what kind of revenue contribution, what kind of end application each of these molecules are supposed to serve, and what kind of customer sets we have been talking about both between Japanese and the non -Japanese? That is my first question.
Last bit. When do we expect the pharma segment to turn EBITDA positive?